Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids
View / Open Files
Authors
Lane, Amelia
Jovanovic, Katarina
Shortall, Ciara
Ottaviani, Daniele
Brugulat-Panes, Anna
Schwarz, Nele
Guarascio, Rosellina
Hayes, Matthew J
Palfi, Arpad
Chadderton, Naomi
Farrar, G Jane
Hardcastle, Alison J
Cheetham, Michael E
Journal Title
Stem Cell Reports
ISSN
2213-6711
Publisher
Elsevier
Language
English
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Lane, A., Jovanovic, K., Shortall, C., Ottaviani, D., Brugulat-Panes, A., Schwarz, N., Guarascio, R., et al. (2020). Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids. Stem Cell Reports https://doi.org/10.1016/j.stemcr.2020.05.007
Abstract
RP2 mutations cause a severe form of X-linked retinitis pigmentosa (XLRP). The mechanism of RP2-associated retinal degeneration in humans is unclear, and animal models of RP2 XLRP do not recapitulate this severe phenotype. Here, we developed gene-edited isogenic RP2 knockout (RP2 KO) induced pluripotent stem cells (iPSCs) and RP2 patient-derived iPSC to produce 3D retinal organoids as a human retinal disease model. Strikingly, the RP2 KO and RP2 patient-derived organoids showed a peak in rod photoreceptor cell death at day 150 (D150) with subsequent thinning of the organoid outer nuclear layer (ONL) by D180 of culture. Adeno-associated virus-mediated gene augmentation with human RP2 rescued the degeneration phenotype of the RP2 KO organoids, to prevent ONL thinning and restore rhodopsin expression. Notably, these data show that 3D retinal organoids can be used to model photoreceptor degeneration and test potential therapies to prevent photoreceptor cell death
Identifiers
External DOI: https://doi.org/10.1016/j.stemcr.2020.05.007
This record's URL: https://www.repository.cam.ac.uk/handle/1810/307707